The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?

被引：0
|
作者：
Migliaccio, I. [1 ]
Biganzoli, L. [1 ]
Malorni, L. [1 ]
机构：
[1] Hosp Prato, Azienda USL Toscana Ctr, Dept Oncol, Prato, Italy
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2024.05.542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：683 / 685
页数：3
相关论文
共 50 条
  • [1] Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer
    Lu, Yunlong
    Liu, Wukun
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15094 - 15114
  • [2] Endocrine-Resistant Breast Cancer: Mechanisms and Treatment
    Hartkopf, Andreas D.
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2020, 15 (04) : 347 - 354
  • [3] The NFκB pathway and endocrine-resistant breast cancer
    Zhou, Y
    Eppenberger-Castori, S
    Eppenberger, U
    Benz, CC
    ENDOCRINE-RELATED CANCER, 2005, 12 : S37 - S46
  • [4] Gene expression profiles in endocrine-resistant breast cancer
    Schagerholm, C.
    Robertson, S.
    Sifakis, E. G.
    Hases, L.
    Williams, C.
    Hartman, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S640 - S640
  • [5] Breast cancer: Recurrent fusions in endocrine-resistant disease
    Romero D.
    Nature Reviews Clinical Oncology, 2018, 15 (4) : 200 - 200
  • [6] Epigenetic Therapy Targets Endocrine-Resistant Breast Cancer
    Genetic Engineering and Biotechnology News, 2024, 44 (04): : 34
  • [7] The genomic landscape of endocrine-resistant metastatic breast cancer
    Razavi, P.
    CANCER RESEARCH, 2020, 80 (04)
  • [8] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [9] Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer
    Zhao, Meng
    Ramaswamy, Bhuvaneswari
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (03): : 248 - 262
  • [10] Exploiting novel models of endocrine-resistant breast cancer to identify new therapeutic targets
    Soosainathan, Arany
    Nikitorowicz-Buniak, Joanna
    Pancholi, Sunil
    Iravani, Marjan
    Alexander, John
    Haider, Syed
    Johnston, Stephen R.
    Dowsett, Mitchell
    Martin, Lesley A.
    Isacke, Clare M.
    CANCER RESEARCH, 2022, 82 (04)
12345